Monitoring response and treatment outcome in patients with chronic phase chronic myeloid leukemia (CML) treated with imatinib.
A. Teitelbaum
Consultant or Advisory Role - Novartis (U)
D. Spencer
Consultant or Advisory Role - Novartis (U)
V. K. Bollu
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
B. Chastek
Consultant or Advisory Role - Novartis (U)
J. Coombs
Employment or Leadership Position - Novartis
Stock Ownership - Novartis
M. Kulakodlu
Consultant or Advisory Role - Novartis (U)
R. Morlock
Consultant or Advisory Role - Novartis (U)